Literature DB >> 15963694

Synergistic effect of antibacterial agents human beta-defensins, cathelicidin LL-37 and lysozyme against Staphylococcus aureus and Escherichia coli.

Xuejun Chen1, François Niyonsaba, Hiroko Ushio, Daiju Okuda, Isao Nagaoka, Shigaku Ikeda, Ko Okumura, Hideoki Ogawa.   

Abstract

BACKGROUND: The antimicrobial properties of the skin are attributed to several agents including human beta-defensins (hBDs), cathelicidin LL-37 and skin lysozyme. Although these antibacterial agents reside in the skin to protect it against infection, it is not well known whether the total analysis of all combinations of these agents may result in synergistic effect to enhance their antibacterial activities against invading microorganisms.
OBJECTIVE: To elucidate the interactions between keratinocyte-derived antibacterial agents in the extracellular milieu, we investigated the individual and synergistic activities of hBDs, LL-37 and lysozyme against Staphylococcus aureus and Escherichia coli in neutral and acidic milieus.
METHODS: The colorimetric method using alamarBlue was employed to assess the antibacterial activities of hBD-1, -2, -3, LL-37 and lysozyme and the viability of bacteria was read spectrophotometrically.
RESULTS: In both neutral and acidic pH milieus, hBD-1, -2, -3, LL-37 and lysozyme exhibited antibacterial activity against S. aureus and E. coli in a dose-dependent manner. Interestingly, the antibacterial activity of hBD-1, -2, -3 and lysozyme but not LL-37 was significantly enhanced in acidic milieu (pH 4.6). Furthermore, various combinations of above agents resulted in a synergistic or additive antibacterial effect against S. aureus and E. coli in neutral milieu. The synergistic effect of hBDs, LL-37 and lysozyme against S. aureus was further significantly enhanced in acidic milieu. In contrast, above antibacterial agents exhibited mainly additive rather than synergistic effect on antibacterial activity against E. coli in acidic milieu.
CONCLUSION: Taken together, these results provide a novel evidence of antimicrobial mechanism of natural human skin-derived antibacterial agents against bacterial infection, and their involvement in innate immunity.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15963694     DOI: 10.1016/j.jdermsci.2005.03.014

Source DB:  PubMed          Journal:  J Dermatol Sci        ISSN: 0923-1811            Impact factor:   4.563


  68 in total

Review 1.  Antimicrobial anxiety: the impact of stress on antimicrobial immunity.

Authors:  Katherine A Radek
Journal:  J Leukoc Biol       Date:  2010-05-04       Impact factor: 4.962

2.  Modulation of early β-defensin-2 production as a mechanism developed by type I Toxoplasma gondii to evade human intestinal immunity.

Authors:  Vijay Morampudi; Michel Y Braun; Sushila D'Souza
Journal:  Infect Immun       Date:  2011-03-07       Impact factor: 3.441

3.  Functional synergy between antimicrobial peptoids and peptides against Gram-negative bacteria.

Authors:  Nathaniel P Chongsiriwatana; Modi Wetzler; Annelise E Barron
Journal:  Antimicrob Agents Chemother       Date:  2011-08-22       Impact factor: 5.191

4.  Fitness level impacts salivary antimicrobial protein responses to a single bout of cycling exercise.

Authors:  Hawley Kunz; Nicolette C Bishop; Guillaume Spielmann; Mira Pistillo; Justin Reed; Teja Ograjsek; Yoonjung Park; Satish K Mehta; Duane L Pierson; Richard J Simpson
Journal:  Eur J Appl Physiol       Date:  2015-01-04       Impact factor: 3.078

5.  Effect of Ipr1 on expression levels of immune genes related to macrophage anti-infection of mycobacterium tuberculosis.

Authors:  Na Li; Pengfei Liu; Lianwen Wang; Jingbo Liu; Xiao Yuan; Wei Meng; Yan Dong; Boqing Li
Journal:  Int J Clin Exp Med       Date:  2015-03-15

6.  A role for antimicrobial peptides in intestinal microsporidiosis.

Authors:  G J Leitch; C Ceballos
Journal:  Parasitology       Date:  2008-12-12       Impact factor: 3.234

7.  Human beta-defensins kill Candida albicans in an energy-dependent and salt-sensitive manner without causing membrane disruption.

Authors:  Slavena Vylkova; Namrata Nayyar; Wansheng Li; Mira Edgerton
Journal:  Antimicrob Agents Chemother       Date:  2006-10-30       Impact factor: 5.191

8.  Dual Functional Lysozyme-Chitosan Conjugate for Tunable Degradation and Antibacterial Activity.

Authors:  Soyon Kim; Jiabing Fan; Chung-Sung Lee; Min Lee
Journal:  ACS Appl Bio Mater       Date:  2020-03-08

9.  Innate immunity in the vagina (Part II): Anti-HIV activity and antiviral content of human vaginal secretions.

Authors:  Mickey V Patel; Mimi Ghosh; John V Fahey; Christina Ochsenbauer; Richard M Rossoll; Charles R Wira
Journal:  Am J Reprod Immunol       Date:  2014-05-08       Impact factor: 3.886

10.  Intramammary expression and therapeutic effect of a human lysozyme-expressing vector for treating bovine mastitis.

Authors:  Huai-chang Sun; Fang-ming Xue; Ke Qian; Hao-xia Fang; Hua-lei Qiu; Xin-yu Zhang; Zhao-hua Yin
Journal:  J Zhejiang Univ Sci B       Date:  2006-04       Impact factor: 3.066

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.